China Nuokang Bio-Pharmaceutical Inc. | Company profile from Hoover's
 
Call Now! 866-464-3202
This is a custom template (Home Pages: Video Center Area - AUTO PLAY WITH MUTED SOUND) that is currently displayed on the following pages: * third column

Video Center

China Nuokang Bio-Pharmaceutical Inc. · Shenyang, Liaoning Province China · (NASDAQ (GM): NKBP)

Company Description

No. 18-1 E. Nanping Rd.,
Hunnan National New & High-tech Development Zone
Shenyang, Liaoning Province
11017-1
China (Map)
Phone: +86-24-2469-6033
Fax: +86-24-2469-6133
    Usually a snake bite happens right before a trip to the hospital, not while you're there. But China Nuokang Bio-Pharmaceutical (dba Nuokang) has developed a drug containing an enzyme found in snake venom that's used to control bleeding after surgery. Called Baquting, the injectable drug is used in hospitals across China, where blood transfusions are not as readily available as they are in the US. Nuokang also distributes the adenosine drugs Aiduo and Aiwen in China, which are used to diagnose heart conditions during stress tests, as well as a dozen other medicines for asthma, infectious diseases, cold and flu, and anemia. Nuokang was founded in 1997. The company went public in the US in late 2009. To read the full description, subscribe now.
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!

    China Nuokang Bio-Pharmaceutical Inc. Reports

    No subscription, no problem.
    Download presentation-ready reports for this company now.
    From company profiles to the competitive landscape, Hoover’s offers immediate access to individual reports.

    Key China Nuokang Bio-Pharmaceutical Inc. Financials

    Company TypePublic - NASDAQ (GM): NKBP

    Fiscal Year-EndDecember
    2008 Employees634

    China Nuokang Bio-Pharmaceutical Inc. Executives

    15 executives listed for China Nuokang Bio-Pharmaceutical Inc.'s Shenyang, Liaoning Province location.
    TitleName & BioContact
    Chairman and CEOBaizhong XueEmail
    CFOTianruo PuEmail
    Chief Scientific OfficerKevin LiEmail

    Competition

    Competitive Landscape for China Nuokang Bio-Pharmaceutical Inc.
    Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.
    Top China Nuokang Bio-Pharmaceutical Inc. Competitors
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!